CMS1 subtype includes MSI tumors with high mutational burden and active anti-tumor responses thanks to high infiltration of anti-tumor cells such as CD8+ T cells, Th1 cells, DCs, NK cells, and M1 macrophages as well as a minimum amount of Treg cells (13, 64, 108). Here, CD8A is linked to neoplasm.